Literature DB >> 30480488

Interreader Variability of Dynamic Contrast-enhanced MRI of Recurrent Glioblastoma: The Multicenter ACRIN 6677/RTOG 0625 Study.

Daniel P Barboriak1, Zheng Zhang1, Pratikkumar Desai1, Bradley S Snyder1, Yair Safriel1, Robert C McKinstry1, Felix Bokstein1, Gregory Sorensen1, Mark R Gilbert1, Jerrold L Boxerman1.   

Abstract

Purpose To evaluate factors contributing to interreader variation (IRV) in parameters measured at dynamic contrast material-enhanced (DCE) MRI in patients with glioblastoma who were participating in a multicenter trial. Materials and Methods A total of 18 patients (mean age, 57 years ± 13 [standard deviation]; 10 men) who volunteered for the advanced imaging arm of ACRIN 6677, a substudy of the RTOG 0625 clinical trial for recurrent glioblastoma treatment, underwent analyzable DCE MRI at one of four centers. The 78 imaging studies were analyzed centrally to derive the volume transfer constant (Ktrans) for gadolinium between blood plasma and tissue extravascular extracellular space, fractional volume of the extracellular extravascular space (ve), and initial area under the gadolinium concentration curve (IAUGC). Two independently trained teams consisting of a neuroradiologist and a technologist segmented the enhancing tumor on three-dimensional spoiled gradient-recalled acquisition in the steady-state images. Mean and median parameter values in the enhancing tumor were extracted after registering segmentations to parameter maps. The effect of imaging time relative to treatment, map quality, imager magnet and sequence, average tumor volume, and reader variability in tumor volume on IRV was studied by using intraclass correlation coefficients (ICCs) and linear mixed models. Results Mean interreader variations (± standard deviation) (difference as a percentage of the mean) for mean and median IAUGC, mean and median Ktrans, and median ve were 18% ± 24, 17% ± 23, 27% ± 34, 16% ± 27, and 27% ± 34, respectively. ICCs for these metrics ranged from 0.90 to 1.0 for baseline and from 0.48 to 0.76 for posttreatment examinations. Variability in reader-derived tumor volume was significantly related to IRV for all parameters. Conclusion Differences in reader tumor segmentations are a significant source of interreader variation for all dynamic contrast-enhanced MRI parameters. © RSNA, 2018 Online supplemental material is available for this article. See also the editorial by Wolf in this issue.

Entities:  

Mesh:

Year:  2018        PMID: 30480488      PMCID: PMC6358054          DOI: 10.1148/radiol.2019181296

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   29.146


  21 in total

1.  3D Slicer as an image computing platform for the Quantitative Imaging Network.

Authors:  Andriy Fedorov; Reinhard Beichel; Jayashree Kalpathy-Cramer; Julien Finet; Jean-Christophe Fillion-Robin; Sonia Pujol; Christian Bauer; Dominique Jennings; Fiona Fennessy; Milan Sonka; John Buatti; Stephen Aylward; James V Miller; Steve Pieper; Ron Kikinis
Journal:  Magn Reson Imaging       Date:  2012-07-06       Impact factor: 2.546

2.  Comparative study into the robustness of compartmental modeling and model-free analysis in DCE-MRI studies.

Authors:  Caleb Roberts; Basma Issa; Andrew Stone; Alan Jackson; John C Waterton; Geoffrey J M Parker
Journal:  J Magn Reson Imaging       Date:  2006-04       Impact factor: 4.813

3.  A pyramid approach to subpixel registration based on intensity.

Authors:  P Thévenaz; U E Ruttimann; M Unser
Journal:  IEEE Trans Image Process       Date:  1998       Impact factor: 10.856

4.  Early post-bevacizumab progression on contrast-enhanced MRI as a prognostic marker for overall survival in recurrent glioblastoma: results from the ACRIN 6677/RTOG 0625 Central Reader Study.

Authors:  Jerrold L Boxerman; Zheng Zhang; Yair Safriel; Mykol Larvie; Bradley S Snyder; Rajan Jain; T Linda Chi; A Gregory Sorensen; Mark R Gilbert; Daniel P Barboriak
Journal:  Neuro Oncol       Date:  2013-06-19       Impact factor: 12.300

5.  An AUC-like index for agreement assessment.

Authors:  Zheng Zhang; Youdan Wang; Fenghai Duan
Journal:  J Biopharm Stat       Date:  2014       Impact factor: 1.051

6.  Inter- and intra-rater reproducibility of quantitative dynamic contrast enhanced MRI using TWIST perfusion data in a uterine fibroid model.

Authors:  Matthew S Davenport; Tobias Heye; Brian M Dale; Jeffrey J Horvath; Steven R Breault; Sebastian Feuerlein; Mustafa R Bashir; Daniel T Boll; Elmar M Merkle
Journal:  J Magn Reson Imaging       Date:  2012-12-12       Impact factor: 4.813

7.  NIH Image to ImageJ: 25 years of image analysis.

Authors:  Caroline A Schneider; Wayne S Rasband; Kevin W Eliceiri
Journal:  Nat Methods       Date:  2012-07       Impact factor: 28.547

8.  Linear least-squares method for unbiased estimation of T1 from SPGR signals.

Authors:  Lin-Ching Chang; Cheng Guan Koay; Peter J Basser; Carlo Pierpaoli
Journal:  Magn Reson Med       Date:  2008-08       Impact factor: 4.668

9.  Cerebral blood volume analysis in glioblastomas using dynamic susceptibility contrast-enhanced perfusion MRI: a comparison of manual and semiautomatic segmentation methods.

Authors:  Seung Chai Jung; Seung Hong Choi; Jeong A Yeom; Ji-Hoon Kim; Inseon Ryoo; Soo Chin Kim; Hwaseon Shin; A Leum Lee; Tae Jin Yun; Chul-Kee Park; Chul-Ho Sohn; Sung-Hye Park
Journal:  PLoS One       Date:  2013-08-08       Impact factor: 3.240

Review 10.  Pitfalls in the neuroimaging of glioblastoma in the era of antiangiogenic and immuno/targeted therapy - detecting illusive disease, defining response.

Authors:  Raymond Y Huang; Martha R Neagu; David A Reardon; Patrick Y Wen
Journal:  Front Neurol       Date:  2015-02-23       Impact factor: 4.003

View more
  7 in total

1.  Reliability of dynamic susceptibility contrast perfusion metrics in pre- and post-treatment glioma.

Authors:  Valentina Kouwenberg; Lusien van Santwijk; Frederick J A Meijer; Dylan Henssen
Journal:  Cancer Imaging       Date:  2022-06-17       Impact factor: 5.605

2.  Multi-contrast four-dimensional magnetic resonance imaging (MC-4D-MRI): Development and initial evaluation in liver tumor patients.

Authors:  Lei Zhang; Fang-Fang Yin; Tian Li; Xinzhi Teng; Haonan Xiao; Wendy Harris; Lei Ren; Feng-Ming Spring Kong; Hong Ge; Ronghu Mao; Jing Cai
Journal:  Med Phys       Date:  2021-11-18       Impact factor: 4.506

3.  Automatic assessment of glioma burden: a deep learning algorithm for fully automated volumetric and bidimensional measurement.

Authors:  Ken Chang; Andrew L Beers; Harrison X Bai; James M Brown; K Ina Ly; Xuejun Li; Joeky T Senders; Vasileios K Kavouridis; Alessandro Boaro; Chang Su; Wenya Linda Bi; Otto Rapalino; Weihua Liao; Qin Shen; Hao Zhou; Bo Xiao; Yinyan Wang; Paul J Zhang; Marco C Pinho; Patrick Y Wen; Tracy T Batchelor; Jerrold L Boxerman; Omar Arnaout; Bruce R Rosen; Elizabeth R Gerstner; Li Yang; Raymond Y Huang; Jayashree Kalpathy-Cramer
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

4.  Repeatability of tumor perfusion kinetics from dynamic contrast-enhanced MRI in glioblastoma.

Authors:  Ryan T Woodall; Prativa Sahoo; Yujie Cui; Bihong T Chen; Mark S Shiroishi; Cristina Lavini; Paul Frankel; Margarita Gutova; Christine E Brown; Jennifer M Munson; Russell C Rockne
Journal:  Neurooncol Adv       Date:  2021-11-22

5.  Preoperative Magnetic Resonance Imaging Radiomics for Predicting Early Recurrence of Glioblastoma.

Authors:  Jing Wang; Xiaoping Yi; Yan Fu; Peipei Pang; Huihuang Deng; Haiyun Tang; Zaide Han; Haiping Li; Jilin Nie; Guanghui Gong; Zhongliang Hu; Zeming Tan; Bihong T Chen
Journal:  Front Oncol       Date:  2021-10-27       Impact factor: 6.244

6.  Evaluation of Multisource Adaptive MRI Fusion for Gross Tumor Volume Delineation of Hepatocellular Carcinoma.

Authors:  Andy Lai-Yin Cheung; Lei Zhang; Chenyang Liu; Tian Li; Anson Ho-Yin Cheung; Chun Leung; Angus Kwong-Chuen Leung; Sai-Kit Lam; Victor Ho-Fun Lee; Jing Cai
Journal:  Front Oncol       Date:  2022-02-25       Impact factor: 6.244

7.  Assessment of the hypervascularized fraction of glioblastomas using a volume analysis of dynamic susceptibility contrast-enhanced MRI may help to identify pseudoprogression.

Authors:  Margaux Roques; Isabelle Catalaa; Magali Raveneau; Justine Attal; Aurore Siegfried; Jean Darcourt; Christophe Cognard; Nicolas Menjot de Champfleur; Fabrice Bonneville
Journal:  PLoS One       Date:  2022-10-13       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.